Arena Pharmaceuticals, Inc. - Common Stock (NQ:ARNA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Mar 10, 2022 Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	99.87 (1)
Ask (Size)	100.00 (88)
Prev. Close	99.98
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	61,074,416
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

NeurAxis: Should You Buy This IPO? ↗

February 08, 2023

As NeurAxis is ready to launch its IPO, we take a closer look to see if investors should be buying into the hype.

Via Talk Markets

NeurAxis IPO Sets Stage To Take On Irritable Bowel Syndrome With A Non-Surgical Solution ↗

February 06, 2023

As NeurAxis gears up for its upcoming IPO, we take a deep dive into the company to see if it's worth adding to your investment portfolio.

Via Talk Markets

Performance

More News

Arena Pharmaceuticals Inc. Climbs To Annual-High Share Price ↗

March 10, 2022

Via Benzinga

Arena Pharmaceuticals Inc. (ARNA) Climbs to Annual-High Share Price

March 10, 2022

Via Investor Brand Network

Arena Pharmaceuticals Inc. (ARNA) Climbs to Annual-High Share Price

March 10, 2022

Via Investor Brand Network

7 Biotech Stocks With Key Catalysts in March ↗

March 09, 2022

Via InvestorPlace

Expert Ratings For Arena Pharmaceuticals ↗

February 09, 2022

Via Benzinga

Bullish Tuesday For Marijuana Stocks - Nine Energy Service, ReneSola Among Top Gainers ↗

March 08, 2022

Via Benzinga

Futures Rebound On "Massive" EU Bond Stimulus Plan; Nickel Halted After Record Surge, Gold Over $2000 ↗

March 08, 2022

Via Talk Markets

Pfizer's Cannabinoid-Related Biotech Company Arena's Q4 Net Loss Grows 27% YoY ↗

February 24, 2022

Via Benzinga

Arena Pharmaceuticals: Q4 Earnings Insights ↗

February 23, 2022

Via Benzinga

Arena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates

February 23, 2022

From Arena Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development ↗

February 23, 2022

Via Benzinga

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 17, 2022

From Arena Pharmaceuticals, Inc.

Via Business Wire

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Via Benzinga

Arena Pharmaceuticals to Release Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update on February 23

February 09, 2022

From Arena Pharmaceuticals, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For February 9, 2022 ↗

February 09, 2022

Via Benzinga

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 18, 2022

From Arena Pharmaceuticals, Inc.

Via Business Wire

7 Long-Term Stocks to Buy and Hold Until 2030 ↗

January 17, 2022

Via InvestorPlace

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 21, 2021

From Arena Pharmaceuticals, Inc.

Via Business Wire

10 Biggest Price Target Changes For Tuesday ↗

December 21, 2021

Via Benzinga

Benzinga's Bulls And Bears Of The Past Week: Pfizer, Bank Of America, Beyond Meat, GameStop, AMC, Overstock And More ↗

December 18, 2021

Via Benzinga

The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More ↗

December 17, 2021

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2021 ↗

December 14, 2021

Via Benzinga

What 6 Analyst Ratings Have To Say About Arena Pharmaceuticals ↗

December 14, 2021

Via Benzinga

Frequently Asked Questions

Is Arena Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Arena Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Arena Pharmaceuticals, Inc. - Common Stock trade on?

Arena Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Arena Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Arena Pharmaceuticals, Inc. - Common Stock is ARNA on the Nasdaq Stock Market